EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Neoadjuvant and perioperative chemoimmunotherapy versus chemotherapy for resectable non-small-cell lung cancer: A systematic review and meta-analysis

Tianze Zhu, Jinxi Zhou, Dewang Liu, Chenhao Li

Cancer Treatment and Research Communications · 2026 · 49 · 101478

DOI: 10.1016/j.ctarc.2026.101478 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Tianze Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College, Tianjin Medical University, Tianjin, 300270, China. Electronic address: Zhutz0305@163.com. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although neoadjuvant and perioperative chemoimmunotherapy improve outcomes in resectable non-small-cell lung cancer, treatment effects remain incompletely defined for specific subgroups. We searched PubMed, Embase, and Web of Science through 3 December 2025 and pooled eight randomized trials involving 3387 patients using random-effects models. Exploratory event-free survival (EFS) analyses yielded hazard ratios (HRs) of 0.57 for perioperative and 0.66 for pure neoadjuvant regimens versus chemotherapy. The indirect ratio of HRs was 0.86 (95% CI, 0.63-1.18; interaction P = 0.347), with insufficient precision to establish equivalence. Among patients with PD-L1 tumor-cell expression

Schlagwörter

Stichwörter der Autor:innen

Immune checkpoint inhibitorsMeta-analysisNeoadjuvant immunotherapyNon-small cell lung cancerPerioperative treatment

Autor:innen und Institutionen

  • Clinical Medical College, Tianjin Medical University, Tianjin, 300270, China. Electronic address: Zhutz0305@163.com.
  • Clinical Medical College, Tianjin Medical University, Tianjin, 300270, China. Electronic address: 17379565686@163.com.
  • Clinical Medical College, Tianjin Medical University, Tianjin, 300270, China. Electronic address: a17325233643@163.com.
  • Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongq…

Zitieren

APA

Zhu, T., Zhou, J., Liu, D., & Li, C. (2026). Neoadjuvant and perioperative chemoimmunotherapy versus chemotherapy for resectable non-small-cell lung cancer: A systematic review and meta-analysis. Cancer Treatment and Research Communications, 49, 101478. https://doi.org/10.1016/j.ctarc.2026.101478

Vancouver

Zhu T, Zhou J, Liu D, Li C. Neoadjuvant and perioperative chemoimmunotherapy versus chemotherapy for resectable non-small-cell lung cancer: A systematic review and meta-analysis. Cancer Treatment and Research Communications. 2026;49:101478. doi:10.1016/j.ctarc.2026.101478

BibTeX
@article{Zhu2026,
  author = {Zhu, Tianze and Zhou, Jinxi and Liu, Dewang and Li, Chenhao},
  title = {Neoadjuvant and perioperative chemoimmunotherapy versus chemotherapy for resectable non-small-cell lung cancer: A systematic review and meta-analysis},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {49},
  pages = {101478},
  doi = {10.1016/j.ctarc.2026.101478}
}
Kostenlos starten →